25th – 27th September 2024 | Rockville, Maryland, USA
The workshop was originally a meeting for FDA statisticians that later expanded to include all statisticians interested in statistical practices for all areas regulated by the FDA. Although the workshop achieved attendance of more than 1,000 statisticians in 2022, it maintains the same grassroots approach for its planning. By bringing both FDA and industry speakers into each session, the highly valued original intent of the conference is maintained.
Sessions
Topic: PS13 Critical Considerations for Selecting Study Endpoints
Date: Thursday, 26 September 2024 | 2:45 PM – 4:00 PM EDT
Session Chair: Brad Carlin, Senior Advisor, Data Science and Statistics
Topic: P18 Machine learning pipeline for biomarker discovery in ultra-high dimensional NGS data with time-to-event outcome
Date: Thursday, 26 September 2024 | 5:45 PM – 6:30 PM EDT
Poster Presentation: Yang Liao, Manager, Development Consulting & Scientific Affairs
Register here: https://www.raps.org/eucrps/home
